Researchers have recently identified common metabolites across cancer types like pancreatic and glioma cancer, suggesting their potential as universal cancer biomarkers.
o It can be used to detect disease, monitor treatment, and predict the risk of developing disease.
Need for Reliable Cancer Biomarkers:o Aggressive cancers like pancreatic and glioma are often diagnosed late and have poor prognoses.
o Non-invasive biomarkers can address gaps in early cancer detection and treatment strategies.